at petros, we are bringing new approaches to the most challenging conditions in men's health. we seek to understand the various health phases throughout a man’s journey. we collaborate with researchers, scientists, medical thought leaders and payers to ensure our therapies aid in restoring men’s body function to vitality.
Company profile
Ticker
PTPI
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Metuchen Pharmaceuticals LLC • Neurotrope, Inc. • Timm Medical Technologies, Inc. • Pos-T-Vac, LLC ...
IRS number
851410058
PTPI stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
22 Mar 24
8-K
Changes in Registrant's Certifying Accountant
12 Jan 24
8-K
Submission of Matters to a Vote of Security Holders
29 Dec 23
8-K
Departure of Directors or Certain Officers
28 Dec 23
ARS
2022 FY
Annual report to shareholders
30 Nov 23
DEF 14A
Definitive proxy
30 Nov 23
10-Q
2023 Q3
Quarterly report
15 Nov 23
NT 10-Q
Notice of late quarterly filing
15 Nov 23
8-K
Amendments to Articles of Incorporation or Bylaws
2 Oct 23
424B3
Prospectus supplement
19 Sep 23
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 17.97 mm | 17.97 mm | 17.97 mm | 17.97 mm | 17.97 mm | 17.97 mm |
Cash burn (monthly) | (no burn) | (no burn) | 1.60 mm | 1.06 mm | 1.35 mm | 578.08 k |
Cash used (since last report) | n/a | n/a | 9.54 mm | 6.29 mm | 8.03 mm | 3.44 mm |
Cash remaining | n/a | n/a | 8.43 mm | 11.68 mm | 9.94 mm | 14.53 mm |
Runway (months of cash) | n/a | n/a | 5.3 | 11.1 | 7.4 | 25.1 |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 16 |
Opened positions | 5 |
Closed positions | 2 |
Increased positions | 3 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 201.01 mm |
Total shares | 8.22 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
John D Shulman | 7.85 mm | $20.33 mm |
Intracoastal Capital | 167.14 k | $0.00 |
Iroquois Capital Management | 103.47 k | $345.00 k |
Vanguard | 31.81 k | $64.58 mm |
Schonfeld Strategic Advisors | 23.20 k | $47.10 mm |
Renaissance Technologies | 16.78 k | $34.00 k |
BLK Blackrock | 16.51 k | $33.52 mm |
BMO Bank of Montreal | 10.00 k | $27.40 mm |
Tower Research Capital | 2.55 k | $5.17 mm |
Emfo | 1.00 k | $2.03 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Dec 23 | Wayne Remell Walker | Stock Option Common Stock | Grant | Acquire A | No | No | 1.41 | 40,000 | 56.40 k | 40,000 |
21 Dec 23 | Mitchell Arnold | Stock Option Common Stock | Grant | Acquire A | No | No | 1.41 | 20,000 | 28.20 k | 20,000 |
21 Dec 23 | Bernstein Bruce | Stock Option Common Stock | Grant | Acquire A | No | No | 1.41 | 40,000 | 56.40 k | 40,000 |
21 Dec 23 | Silverman Joshua | Stock Option Common Stock | Grant | Acquire A | No | No | 1.41 | 40,000 | 56.40 k | 40,000 |
21 Dec 23 | Fady Boctor | Common Stock | Grant | Acquire A | No | No | 0 | 49,645 | 0.00 | 49,645 |
21 Dec 23 | Fady Boctor | Stock Option Common Stock | Grant | Acquire A | No | No | 1.41 | 54,533 | 76.89 k | 54,533 |
News
12 Health Care Stocks Moving In Tuesday's After-Market Session
30 Jan 24
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
30 Jan 24
Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
30 Jan 24
12 Health Care Stocks Moving In Thursday's After-Market Session
25 Jan 24
12 Health Care Stocks Moving In Wednesday's After-Market Session
17 Jan 24
Press releases
BestGrowthStocks.Com Issues Comprehensive Analysis of Petros Pharmaceuticals Inc
11 Mar 24
Petros Pharmaceuticals Enters into AI Licensing Agreement with Leading Multi-Billion-Dollar Software Provider
14 Feb 24
Thinking about buying stock in Helius Medical Technologies, Peraso, GDS Holdings, Everbridge, or Petros Pharmaceuticals?
6 Feb 24
Thinking about buying stock in Agape ATP, Tempest Therapeutics, Nu Holdings, Bristol-Myers Squibb, or Petros Pharmaceuticals?
30 Jan 24
Thinking about buying stock in Petros Pharmaceuticals, Xpeng Inc, Nukkleus, Cellectar Biosciences, or bluebird bio?
25 Jan 24